HART IPO Set For Early April, Harvard Bioscience To Spin Off Remaining 83% Stake In 120 Days

By |
0 Comment
In December, Harvard Bioscience(HBIO) filed for an IPO of Harvard Apparatus Regenerative Technologies(HART). Last week, the company announced that the tax free spinoff was approved by the IRS, and that an IPO of 17% of the company would be conducted in early April at an expected price of $10-$12 per share. The company will spin off the remaining 83% to shareholders 120 days after the offering closes.

Disclosure: The author holds no position in any stock mentioned

Related articles

Your post must include a link to this post.

How does this work?
Write a response on your own website and include a link to this post. Then submit your response’s URL here. Your response may appear here after moderation. To update or remove it, edit or delete your original post and submit the same URL again. Learn more about Webmentions.